Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis

BACKGROUND: Aclidinium bromide is a new long-acting muscarinic antagonist (LAMA) indicated for maintenance bronchodilator treatment of chronic obstructive pulmonary disease (COPD). The efficacy of aclidinium was compared with tiotropium and glycopyrronium, using a network meta-analysis (NMA) of rand...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Karabis, Andreas, Lindner, Leandro, Mocarski, Michelle, Huisman, Eline, Greening, Andrew
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2013
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3772873/
https://ncbi.nlm.nih.gov/pubmed/24043936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S48967
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky